rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John Cipriano

Senior Vice President

Company insider

Files Form 4 as: Senior Vice President, Cel-Sci.

In numbers

Trades disclosed
48
Buys
1
Sells
5
Bought
$9,120
Sold
$540K
Companies
1
Companies where not an officer
0
First trade
30 Dec 2005
Last trade
14 Aug 2026
Last filed
17 Aug 2026

Companies traded

Where they are an officer
CVM Cel-SciOfficer · Biotechnology · last 14 Aug 20261 buy · 5 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Aug 2026filed 17 Aug 2026CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$80080,000 at $0.01filing
14 Aug 2026filed 17 Aug 2026CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$80080,000 at $0.01filing
28 Jul 2025filed 29 Jul 2025CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$757,500 at $0.01filing
8 Aug 2023filed 10 Aug 2023CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$65065,000 at $0.01filing
13 Jun 2022filed 14 Jun 2022CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$65065,000 at $0.01filing
19 Nov 2021filed 29 Nov 2021CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$50050,000 at $0.01filing
14 May 2021filed 17 May 2021CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,300130,000 at $0.01filing
22 Apr 2021filed 23 Apr 2021CVM Cel-SciBiotechnologySEC FORM 4 Sold$244K10,000 at $24.38filing
13 Nov 2020filed 16 Nov 2020CVM Cel-SciBiotechnologySEC FORM 4 Sold$127K10,000 at $12.73filing
20 Apr 2020filed 20 Apr 2020CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,600160,000 at $0.01filing
17 Sep 2019filed 18 Sep 2019CVM Cel-SciBiotechnologySEC FORM 4 Sold$70K8,000 at $8.69filing
28 Aug 2019filed 29 Aug 2019CVM Cel-SciBiotechnologySEC FORM 4 Sold$56K8,000 at $7.03filing
7 May 2019filed 8 May 2019CVM Cel-SciBiotechnologySEC FORM 4 Code A$20K2,915 at $6.86filing
11 Apr 2019filed 12 Apr 2019CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$2,069206,880 at $0.01filing
13 Aug 2018filed 15 Aug 2018CVM Cel-SciBiotechnologySEC FORM 4 Code A$40K48,193 at $0.83filing
1 May 2018filed 3 May 2018CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$13313,347 at $0.01filing
1 May 2018filed 3 May 2018CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,350135,000 at $0.01filing
16 Aug 2017filed 17 Aug 2017CVM Cel-SciBiotechnologySEC FORM 4 Sold$43K17,109 at $2.52filing
28 Jul 2017filed 1 Aug 2017CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$90090,000 at $0.01filing
13 Jul 2016filed 19 Jul 2016CVM Cel-SciBiotechnologySEC FORM 4 Code A$6,15713,100 at $0.47filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Geert R. KerstenChief Executive Officer · Chief Executive Officer at Cel Sci, filing Form 4 there in the last year
Patricia B. PrichepChief Financial Officer · Chief Financial Officer at Cel Sci, filing Form 4 there in the last year
Eyal TalorChief Scientific Officer · Chief Scientific Officer at Cel Sci, filing Form 4 there in the last year
Robert Eugene WatsonDirector · Director at Cel Sci, filing Form 4 there in the last year
Bruno Jean-Marie BaillavoineDirector · Director at Cel Sci, filing Form 4 there in the last year